UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Structure-based drug-development study against fibroblast growth factor receptor 2: molecular docking and Molecular dynamics simulation approaches

Scientific reports, 2024-08, Vol.14 (1), p.19439-13, Article 19439

2024

Volltextzugriff (PDF)

Hand-foot syndrome after taking fibroblast growth factor receptor 2 inhibitor

Dermatologie (Heidelberg, Germany), 2024-10, Vol.75 (Suppl 1), p.12

2024

Volltextzugriff (PDF)

Clinicopathological characteristics and prognosis of combined hepatocellular cholangiocarcinoma

BMC cancer, 2024-10, Vol.24 (1), p.1232-14, Article 1232

2024

Volltextzugriff (PDF)

Inflammatory Mediators Suppress FGFR2 Expression in Human Keratinocytes to Promote Inflammation

Molecular and cellular biology, 2024, Vol.44 (11), p.489-504

2024

Volltextzugriff (PDF)

Synthesis and identification of a selective FGFR2 degrader with potent antiproliferative effects in gastric cancer

European journal of medicinal chemistry, 2024-11, Vol.277, p.116780, Article 116780

2024

Volltextzugriff (PDF)

Genome-wide association studies for pelvic organ prolapse in the Japanese population

Communications biology, 2024-09, Vol.7 (1), p.1188-9, Article 1188

2024

Volltextzugriff (PDF)

Successful Long-term Treatment with Modified Dose Pemigatinib in FGFR2-BICC1 Intrahepatic Cholangiocarcinoma: A Case Report

Journal of cancer research and practice, 2024-09, Vol.11 (3), p.114-117

2024

Volltextzugriff (PDF)

Exploring the Horizon: Anti-Fibroblast Growth Factor Receptor Therapy in Pancreatic Cancer with Aberrant Fibroblast Growth Factor Receptor Expression-A Scoping Review

Cancers, 2024-08, Vol.16 (16), p.2912

2024

Volltextzugriff (PDF)

Racial and Sex Differences in Genomic Profiling of Intrahepatic Cholangiocarcinoma

Annals of surgical oncology, 2024-09, Vol.31 (13), p.9071-9078

2024

Volltextzugriff (PDF)

NRASQ61R‐driven atypical melanocytic tumor with blue nevus‐like morphology: A case report

Journal of cutaneous pathology, 2024-12, Vol.51 (12), p.948-953

2024

Volltextzugriff (PDF)

New CRISPR/Cas9-based Fgfr2C361Y/+ mouse model of Crouzon syndrome exhibits skull and behavioral abnormalities

Journal of molecular medicine (Berlin, Germany), 2024-10, Vol.102 (10), p.1255-1266

2024

Volltextzugriff (PDF)

YAP‐TEAD inhibition is associated with upregulation of an androgen receptor mediated transcription program providing therapeutic escape

FEBS open bio, 2024-11, Vol.14 (11), p.1873-1887

2024

Volltextzugriff (PDF)

Developing New Peptides and Peptide-Drug Conjugates for Targeting the FGFR2 Receptor-Expressing Tumor Cells and 3D Spheroids

Biomimetics (Basel, Switzerland), 2024-09, Vol.9 (9), p.515

2024

Volltextzugriff (PDF)

A phase I drug–drug interaction study to assess the effect of futibatinib on P‐gp and BCRP substrates and of P‐gp inhibition on the pharmacokinetics of futibatinib

Clinical and translational science, 2024-09, Vol.17 (9), p.e70012-n/a

2024

Volltextzugriff (PDF)

Ocular manifestations and treatment progress of Crouzon syndrome

International ophthalmology, 2024-09, Vol.44 (1), p.367, Article 367

2024

Volltextzugriff (PDF)

Optic canal stenosis in Crouzon syndrome: a case report and literature review

Zhurnal voprosy neĭrokhirurgii imeni N. N. Burdenko, 2024, Vol.88 (4), p.100

2024

Volltextzugriff (PDF)

MAPK pathway alterations in polymorphous low-grade neuroepithelial tumor of the young: diagnostic considerations

Brain tumor pathology, 2024-10, Vol.41 (3-4), p.109-116

2024

Volltextzugriff (PDF)

New CRISPR/Cas9-based Fgfr2 C361Y/+ mouse model of Crouzon syndrome exhibits skull and behavioral abnormalities

Journal of molecular medicine (Berlin, Germany), 2024-10, Vol.102 (10), p.1255

2024

Volltextzugriff (PDF)

Exploring angiogenic pathways in breast cancer: Clinicopathologic correlations and prognostic implications based on gene expression profiles from a large-scale genomic dataset

PloS one, 2024-09, Vol.19 (9), p.e0310557

2024

Volltextzugriff (PDF)

Fibroblast growth factor 2 promotes osteo/odontogenic differentiation in stem cells from the apical papilla by inhibiting PI3K/AKT pathway

Scientific reports, 2024-08, Vol.14 (1), p.19354-9

2024

Volltextzugriff (PDF)

Fibroblast Growth Factor 2 (FGF2) Activates Vascular Endothelial Growth Factor (VEGF) Signaling in Gastrointestinal Stromal Tumors (GIST): An Autocrine Mechanism Contributing to Imatinib Mesylate (IM) Resistance

Cancers, 2024-09, Vol.16 (17), p.3103

2024

Volltextzugriff (PDF)

VEGF-dependent testicular vascularisation involves MEK1/2 signalling and the essential angiogenesis factors, SOX7 and SOX17

BMC biology, 2024-10, Vol.22 (1), p.222-24, Article 222

2024

Volltextzugriff (PDF)

Regulation of intercellular viscosity by E-cadherin-dependent phosphorylation of EGFR in collective cell migration

Proceedings of the National Academy of Sciences - PNAS, 2024-09, Vol.121 (37), p.e2405560121

2024

Volltextzugriff (PDF)

MicroRNA expression profiles in plasma exosomes of late pregnant giant pandas

Molecular biology reports, 2024-12, Vol.51 (1), p.1068, Article 1068

2024

Volltextzugriff (PDF)

FGFR1 governs iron homeostasis via regulating intracellular protein degradation pathways of IRP2 in prostate cancer cells

Communications biology, 2024-08, Vol.7 (1), p.1011-13

2024

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Aktive Filter

Neu hinzugefügt... seit 90 Tagen

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(32)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(27)
Life Sciences & Biomedicine
(23)
Humans
(18)
Fibroblast Growth Factor Receptor 2
(12)
Animals
(10)
Kinases
(10)
Female
(9)
Mutation
(9)
Tumors
(9)
Growth Factors
(8)
Male
(8)
Middle Aged
(7)
Oncology
(7)
Receptor, Fibroblast Growth Factor, Type 2 - Genetics
(7)
Fibroblast Growth Factor 2
(6)
Fibroblast Growth Factor Receptor 1
(6)
Fibroblasts
(6)
Mice
(6)
Patients
(6)
Adult
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Structure-based drug-development study against fibroblast growth factor receptor 2: molecular docking and Molecular dynamics simulation approaches

Hand-foot syndrome after taking fibroblast growth factor receptor 2 inhibitor

Clinicopathological characteristics and prognosis of combined hepatocellular cholangiocarcinoma

Inflammatory Mediators Suppress FGFR2 Expression in Human Keratinocytes to Promote Inflammation

Synthesis and identification of a selective FGFR2 degrader with potent antiproliferative effects in gastric cancer

Genome-wide association studies for pelvic organ prolapse in the Japanese population

Successful Long-term Treatment with Modified Dose Pemigatinib in FGFR2-BICC1 Intrahepatic Cholangiocarcinoma: A Case Report

Exploring the Horizon: Anti-Fibroblast Growth Factor Receptor Therapy in Pancreatic Cancer with Aberrant Fibroblast Growth Factor Receptor Expression-A Scoping Review

Racial and Sex Differences in Genomic Profiling of Intrahepatic Cholangiocarcinoma

NRASQ61R‐driven atypical melanocytic tumor with blue nevus‐like morphology: A case report

New CRISPR/Cas9-based Fgfr2C361Y/+ mouse model of Crouzon syndrome exhibits skull and behavioral abnormalities

YAP‐TEAD inhibition is associated with upregulation of an androgen receptor mediated transcription program providing therapeutic escape

Developing New Peptides and Peptide-Drug Conjugates for Targeting the FGFR2 Receptor-Expressing Tumor Cells and 3D Spheroids

A phase I drug–drug interaction study to assess the effect of futibatinib on P‐gp and BCRP substrates and of P‐gp inhibition on the pharmacokinetics of futibatinib

Ocular manifestations and treatment progress of Crouzon syndrome

Optic canal stenosis in Crouzon syndrome: a case report and literature review

MAPK pathway alterations in polymorphous low-grade neuroepithelial tumor of the young: diagnostic considerations

New CRISPR/Cas9-based Fgfr2 C361Y/+ mouse model of Crouzon syndrome exhibits skull and behavioral abnormalities

Exploring angiogenic pathways in breast cancer: Clinicopathologic correlations and prognostic implications based on gene expression profiles from a large-scale genomic dataset

Fibroblast growth factor 2 promotes osteo/odontogenic differentiation in stem cells from the apical papilla by inhibiting PI3K/AKT pathway

Fibroblast Growth Factor 2 (FGF2) Activates Vascular Endothelial Growth Factor (VEGF) Signaling in Gastrointestinal Stromal Tumors (GIST): An Autocrine Mechanism Contributing to Imatinib Mesylate (IM) Resistance

VEGF-dependent testicular vascularisation involves MEK1/2 signalling and the essential angiogenesis factors, SOX7 and SOX17

Regulation of intercellular viscosity by E-cadherin-dependent phosphorylation of EGFR in collective cell migration

MicroRNA expression profiles in plasma exosomes of late pregnant giant pandas

FGFR1 governs iron homeostasis via regulating intracellular protein degradation pathways of IRP2 in prostate cancer cells

Aktive Filter

Suchergebnisse filtern